home / stock / numif / numif news


NUMIF News and Press, Numinus Wellness Inc. From 03/26/24

Stock Information

Company Name: Numinus Wellness Inc.
Stock Symbol: NUMIF
Market: OTC
Website: numinus.ca

Menu

NUMIF NUMIF Quote NUMIF Short NUMIF News NUMIF Articles NUMIF Message Board
Get NUMIF Alerts

News, Short Squeeze, Breakout and More Instantly...

NUMIF - PharmAla Biotech signs sale agreement with Numinus Wellness

2024-03-26 09:25:28 ET More on Pharmala Biotech Holdings Inc., Numinus Wellness, etc. Numinus Wellness Inc. (NUMIF) Q1 2024 Earnings Call Transcript Financial information for Pharmala Biotech Holdings Inc. Seeking Alpha’s Quant Rating on Numinus Wellness ...

NUMIF - Numinus Wellness Submits Clinical Trial Application

Numinus Wellness Submits Clinical Trial Application Canada NewsWire VANCOUVER, BC , March 20, 2024 /CNW/ - Numinus Wellness Inc. (" Numinus " or the " Company ") (TSX: NUMI) (OTCQX: NUMIF), a mental health care company advancing traditional and innova...

NUMIF - Numinus Wellness Provides Corporate Update

Numinus Wellness Provides Corporate Update Canada NewsWire Announces Date of Annual General Meeting, Appointment of Directors, and Interim Chief Financial Officer VANCOUVER, BC , March 12, 2024 /CNW/ - Numinus Wellness Inc. (" Numinus " or the " Com...

NUMIF - Numinus Wellness Congratulates MindMed on Positive Results from Phase 2B Clinical Trials of MM120 for Generalized Anxiety Disorder

Numinus Wellness Congratulates MindMed on Positive Results from Phase 2B Clinical Trials of MM120 for Generalized Anxiety Disorder Canada NewsWire VANCOUVER, BC , March 8, 2024 /CNW/ - Numinus Wellness Inc. (" Numinus " or the " Company ") (TSX: NUMI)...

NUMIF - Mind Medicine sends psychedelic stocks higher after FDA status for LSD formulation

2024-03-07 11:29:12 ET More on Clearmind Medicine, Bright Minds, etc. Mind Medicine (MindMed) Inc. (MNMD) Q4 2023 Earnings Call Transcript Mind Medicine: Positive MM-120 Data Leads To Other 2024 Catalysts De-Risking Psychedelics: Compass Pathways, Cybin And Atai ...

NUMIF - Psychedelic stocks gain after FDA priority review for MDMA therapy

2024-02-12 12:13:32 ET More on ATAI, COMPASS Pathways, etc. Compass Pathways: Psilocybin Developer A Potentially Intriguing, Contrarian Play Mind Medicine: Positive MM-120 Data Leads To Other 2024 Catalysts De-Risking Psychedelics: Compass Pathways, Cybin And Atai ...

NUMIF - Numinus Wellness Inc. Announces $6 Million Bought Deal Public Offering with Leads Orders from MAPS and Integrated V.C.

THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES. VANCOUVER, British Columbia, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Numinus Wellness Inc. ("Numinus" or the "Company") ...

NUMIF - Numinus Wellness reports Q1 results

2024-01-16 00:59:17 ET More on Numinus Wellness Seeking Alpha’s Quant Rating on Numinus Wellness Historical earnings data for Numinus Wellness Financial information for Numinus Wellness For further details see: Numinus Wellness reports Q1 results

NUMIF - Numinus Wellness Inc. (NUMIF) Q1 2024 Earnings Call Transcript

2024-01-15 20:01:04 ET Numinus Wellness Inc. (NUMIF) Q1 2024 Earnings Conference Call January 15, 2024 05:30 PM ET Company Participants Craig MacPhail - IR Payton Nyquvest - Founder & CEO Nikhil Handa - CFO Conference Call Participants Michael Oku...

NUMIF - Numinus Wellness Inc. Announces First Quarter Fiscal 2024 Results

Numinus Wellness Inc. Announces First Quarter Fiscal 2024 Results Canada NewsWire Q1 Fiscal 2024 Highlights Gross profit of $2.1 million , an 18.8% increase over Q4 2023 Revenue of $5.9 million , a 3.0% decline over Q4 2023 Reduced operating expenditure...

Previous 10 Next 10